Literature DB >> 18462589

Does antiretroviral therapy prevent HIV transmission to sexual partners?

Tahaniyat Lalani1, Charles Hicks.   

Abstract

The majority of HIV-1 infections are acquired sexually, and interventions to prevent sexual transmission are urgently needed to curb the growth of the HIV pandemic. The potential role of antiretroviral therapy in preventing sexual transmission of HIV is still emerging. Highly active antiretroviral therapy has been shown to decrease HIV RNA shedding in the genital tract, and its use among serodiscordant couples has been associated with reduced seroconversions in partners who are HIV negative. However, other studies have associated the use of antiretroviral therapy with increased HIV transmission risk behaviors. In this review, we explore the rationale for using highly active antiretroviral therapy to prevent sexual transmission of HIV including its role in prevention strategies at the population level, as well as the cost-effectiveness and potential limitations of this approach.

Entities:  

Year:  2008        PMID: 18462589     DOI: 10.1007/s11908-008-0025-8

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  29 in total

1.  Heterosexual transmission of HIV-1 is associated with high plasma viral load levels and a positive viral isolation in the infected partner.

Authors:  M A Pedraza; J del Romero; F Roldán; S García; M C Ayerbe; A R Noriega; J Alcamí
Journal:  J Acquir Immune Defic Syndr       Date:  1999-06-01       Impact factor: 3.731

Review 2.  Could widespread use of combination antiretroviral therapy eradicate HIV epidemics?

Authors:  J X Velasco-Hernandez; H B Gershengorn; S M Blower
Journal:  Lancet Infect Dis       Date:  2002-08       Impact factor: 25.071

3.  HIV prevention research in a resource-limited setting: the experience of planning a trial in Cambodia.

Authors:  Kimberly Page-Shafer; Vonthanak Saphonn; Ly Penh Sun; Mean Chhi Vun; David A Cooper; John M Kaldor
Journal:  Lancet       Date:  2005-09-01       Impact factor: 79.321

4.  Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV.

Authors:  Jesús Castilla; Jorge Del Romero; Victoria Hernando; Beatriz Marincovich; Soledad García; Carmen Rodríguez
Journal:  J Acquir Immune Defic Syndr       Date:  2005-09-01       Impact factor: 3.731

Review 5.  The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic.

Authors:  Julio S G Montaner; Robert Hogg; Evan Wood; Thomas Kerr; Mark Tyndall; Adrian R Levy; P Richard Harrigan
Journal:  Lancet       Date:  2006-08-05       Impact factor: 79.321

6.  A tale of two futures: HIV and antiretroviral therapy in San Francisco.

Authors:  S M Blower; H B Gershengorn; R M Grant
Journal:  Science       Date:  2000-01-28       Impact factor: 47.728

7.  Association between paired plasma and cervicovaginal lavage fluid HIV-1 RNA levels during 36 months.

Authors:  Susan Cu-Uvin; Brad Snyder; Joseph I Harwell; Joseph Hogan; Carla Chibwesha; Dawn Hanley; Jessica Ingersoll; Jaclynn Kurpewski; Kenneth H Mayer; Angela M Caliendo
Journal:  J Acquir Immune Defic Syndr       Date:  2006-08-15       Impact factor: 3.731

8.  Male viral load and heterosexual transmission of HIV-1 subtype E in northern Thailand.

Authors:  Sodsai Tovanabutra; Valerie Robison; Jeerang Wongtrakul; Supaluk Sennum; Vinai Suriyanon; Duangnapa Kingkeow; Surinda Kawichai; Praijitr Tanan; Ann Duerr; Kenrad E Nelson
Journal:  J Acquir Immune Defic Syndr       Date:  2002-03-01       Impact factor: 3.731

9.  Advancing HIV prevention: new strategies for a changing epidemic--United States, 2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-04-18       Impact factor: 17.586

10.  A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group.

Authors:  D M Cardo; D H Culver; C A Ciesielski; P U Srivastava; R Marcus; D Abiteboul; J Heptonstall; G Ippolito; F Lot; P S McKibben; D M Bell
Journal:  N Engl J Med       Date:  1997-11-20       Impact factor: 91.245

View more
  4 in total

1.  Expanding the horizons: new approaches to providing HIV testing services in the United States.

Authors:  Travis H Sanchez; Patrick S Sullivan
Journal:  Public Health Rep       Date:  2008 Nov-Dec       Impact factor: 2.792

Review 2.  Is expanded HIV treatment preventing new infections? Impact of antiretroviral therapy on sexual risk behaviors in the developing world.

Authors:  Kartik K Venkatesh; Timothy P Flanigan; Kenneth H Mayer
Journal:  AIDS       Date:  2011-10-23       Impact factor: 4.177

3.  Understanding people who have never received HIV medical care: a population-based approach.

Authors:  Jennifer L Fagan; Jeanne Bertolli; A D McNaghten
Journal:  Public Health Rep       Date:  2010 Jul-Aug       Impact factor: 2.792

4.  Adherence, sexual risk, and viral load in HIV-infected women prescribed antiretroviral therapy.

Authors:  Marcia McDonnell Holstad; Colleen Diiorio; Frances McCarty
Journal:  AIDS Patient Care STDS       Date:  2011-06-11       Impact factor: 5.078

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.